전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved65 programs
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Advanced Esophageal Cancer · Malignant Glioma of Brain

#MalignantGliomaofBrain#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 7Status Active
CGTLimited DatastaleUTC Therapeutics Inc.Preclinical

Anti-HER2 CAR-T cells (Anti-HER2 CAR-T cells)

HER2-positive Advanced Malignant Solid Tumors · HER2

#HER2#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 6Status Recruiting
CGTLimited DatastaleHrain Biotechnology Co., Ltd.Phase 1

anti-meso-CAR vector transduced T cells (anti-meso-CAR vector transduced T cells)

Malignant Mesothelioma; Pancreatic Cancer · Malignant Mesothelioma

#MalignantMesothelioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Active
AntibodyLimited DatastaleRocheApproved

atezolizumab (Tecentriq, Atezolizumab Injection [Tecentriq])

Hepatocellular Carcinoma · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Approved#monoclonal-antibody#HepatocellularCarcinoma+1
Trials 2Status Active
CGTLimited DatastaleFred Hutchinson Cancer CenterPhase 2

Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes (Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes)

Acute Myeloid Leukemia; EBV-Positive Neoplastic Cells Present · Advanced Pleural Malignant Mesothelioma

#AdvancedPleuralMalignantMesothel#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Discontinued
CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 2

CAR-CD19 T Cells (CAR-CD19 T Cells)

CD19 Positive Malignant B-cell Leukemia and Lymphoma · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

HF10 plus Ipilimumab (HF10 plus Ipilimumab)

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 2Status Active
CGTLimited DatastaleBristol-Myers SquibbPhase 1

IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells)

Metastatic Malignant Solid Neoplasm; Metastatic Melanoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

nivolumab (Opdivo, Adjuvant nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#The
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Pudong HospitalPhase 1

Anti-CDH17 CAR-T cells (Anti-CDH17 CAR-T cells)

CDH17-positive Advanced Malignant Solid Tumors · CDH17-positive Advanced Malignant Solid

#CDH17-positiveAdvancedMalignantS#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleOhio State University Comprehen…Phase 1

Anti-GARP Chimeric Antigen Receptor-T Cells (Anti-GARP Chimeric Antigen Receptor-T Cells)

Recurrent Malignant Glioma; Recurrent WHO Grade 3 Glioma · Recurrent Malignant Glioma

#RecurrentMalignantGlioma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAlbert Einstein College of Medi…Phase 1

Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes (Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes)

HLA-A2 Positive Cells Present; Metastatic Malignant Neoplasm · HLA-A2 Positive Cells Present

#HLA-A2PositiveCellsPresent#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleThe Sixth Affiliated Hospital o…Phase 1

CAR-T therapy for nectin4-positive malignant solid tumor (CAR-T therapy for nectin4-positive malignant solid tumor)

Nectin4-positive Advanced Malignant Solid Tumor · Nectin4-positive Advanced Malignant Soli

#Nectin4-positiveAdvancedMalignan#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleMarcela V. Maus, M.D.,Ph.D.Phase 1

CARv3-TEAM-E T cells (CARv3-TEAM-E T cells)

Glioblastoma; Malignant Glioma · Glioblastoma

#Glioblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleNeovii BiotechPhase 3

Removab (Catumaxomab, Catumaxomab (Removab))

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast); Malignant Ascites · EpCam Positive Tumor (e.g.Ovarian, Gastr

#EpCamPositiveTumoregOvarianGastr#Antibody#Phase3#monoclonal-antibody#EpCamPositiveTumoregOvarian+3
Trials 1Status Active
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 1

Chimeric antigen receptor modified γδ T cells (Chimeric antigen receptor modified γδ T cells)

CAR; Malignant Tumors · CAR

#CAR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleCity of Hope Medical CenterPhase 1

pembrolizumab (Keytruda, Copper Cu 64-DOTA-pembrolizumab)

Metastatic Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm

#MetastaticMalignantSolidNeoplasm#Antibody#Phase1#monoclonal-antibody#City
Trials 1Status Discontinued
CGTLimited DatastaleSichuan UniversityPhase 1

Dual-targeting HER2 and PD-L1 CAR-T cells (Dual-targeting HER2 and PD-L1 CAR-T cells)

Peritoneal Carcinoma Metastatic; Pleural Effusion, Malignant · HER2

#HER2#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting

2 / 4 pages

← PreviousNext →